MUC1
Mucin-1
As of the edition of 20 October 2026, MUC1 (mucin-1, UniProt P15941) has 9 drugs tested at it and 8 companies on the list, 5 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P15941
- How well studied
- Chemical tools exist; no approved drug acts on it
- Where it sits in the cell
- In more than one place
- Solved structures
- 23
- Disease areas
- Cancer; Lungs and airways; Digestive system; Blood and lymph; Hormones; Skin and connective tissue; Heart and blood vessels; Immune system
- Registered trials of its drugs
- 30
Drugs at this target
| Status | Count |
|---|---|
| Active | 2 |
| Went quiet | 2 |
| Stopped | 4 |
| Status not established | 1 |
| Total | 9 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Tecemotide | Went quiet | Phase 3 | none listed |
| HUHMFG1 | Stopped | Phase 2 | none listed |
| GO-203-2C | Stopped | Phase 2 | none listed |
| Cantuzumab ravtansine | Stopped | Phase 2 | none listed |
| DS-3939a | Active | Phase 2 | none listed |
| Gatipotuzumab | Went quiet | Phase 2 | none listed |
| SAR-566658 | Stopped | Phase 2 | none listed |
| DM002 | Active | Phase 2 | none listed |
| M1231 | Status not established | Phase 1 | none listed |
9 of 9 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 5 |
| Engaged | 2 |
| Undetermined | 1 |
| Total on the list | 8 |
The other 5 companies at MUC1
In the product8 companies in all; 5 are not named here, and no score is.
See the 8 companies at MUC1, ranked, with the facts behind eachRequest access. Nothing is shown until you do.